US 7,534,435 B2
	Glycosylated specificity exchangers
Matti Sällberg, Alvsjo (Sweden); Anders Vahlne, Båstad (Sweden); and Maria Perdomo, Märynummi (Finland)
Assigned to Tripep AB, Huddinge (Sweden)
Filed on Apr. 26, 2006, as Appl. No. 11/411,294.
Application 11/411294 is a continuation of application No. 10/913754, filed on Aug. 06, 2004.
Application 10/913754 is a continuation in part of application No. 10/773628, filed on Feb. 05, 2004.
Claims priority of provisional application 60/446172, filed on Feb. 06, 2003.
Prior Publication US 2006/0194247 A1, Aug. 31, 2006
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 39/00 (2006.01); A61K 39/385 (2006.01); A61K 38/116 (2006.01); A01N 61/00 (2006.01)

U.S. Cl. 424—184.1  [424/193.1; 424/196.1; 514/1; 514/8]

12 Claims

1. An isolated glycoconjugate peptide joined to a support, wherein said glycoconjugate peptide comprises an HIV gp120 binding fragment of CD4 less than 20 amino acids in length synthetically conjugated to gal α (1,3) gal β.